Middle East And Africa Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, The Middle East And Africa Cell and Gene Therapy Manufacturing QC Market was valued at USD 89.12 Million in 2024 and is projected to reach USD 179.36 Million by 2028, expanding at a CAGR of 19% during the forecast period. This growth is largely driven by the increasing demand in industries such as pharmaceuticals, biotechnology, and healthcare. Innovative upgrades in drug development and therapeutics, combined with rising awareness about gene therapy's potential for life-threatening diseases, are propelling market expansion. Trends towards green production and sustainability, coupled with technological advancements, offer significant opportunities for market growth. Moreover, the robust export potential of the region strengthens the market position further. The Middle East and Africa are strategically positioning themselves as fundamental players in the cell and gene therapy manufacturing QC market, promising a prosperous future.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market Highlights
- In 2024, Cell Therapy emerged as the dominant Therapy Type based on market size.
- Gene Therapy is projected to register the fastest growth, positioning it as the most attractive Therapy Type segment over the forecast horizon.
- In 2024, Middle East And Africa accounted for 3.99% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is projected to lead the global market in terms of market size.
- South Africa is projected to emerge as the fastest-growing market in Middle East And Africa, reaching USD 5913 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 89.12 Million |
| Market Size In 2028 | USD 179.36 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 19% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Country 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Middle East And Africa Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
